Integrated analyses and a novel nomogram for the prediction of significant fibrosis in patients
LTBP2 may be a new biomarker for liver fibrosis patients. The nomogram showed better diagnostic performance in patients.
Authors
- Shuai Tao
- Conglin Zhao (ORCID: https://orcid.org/0000-0002-7814-3920)
- Yi Zhang (ORCID: https://orcid.org/0000-0003-3524-2854)
- Yuxian Huang (ORCID: https://orcid.org/0000-0001-9934-3588)
- Qiankun Hu (ORCID: https://orcid.org/0000-0002-7024-7047)
- Cong Du
- Qiong Yang (ORCID: https://orcid.org/0000-0002-0601-5073)
- Qiang Li (ORCID: https://orcid.org/0000-0003-3831-9001)
- Xinyan Li (ORCID: https://orcid.org/0000-0003-4514-5695)
- Liang Chen (ORCID: https://orcid.org/0000-0002-4875-5811)
- Shuangshuang Sun
- Wen-Kai Lin
- Neng Wang (ORCID: https://orcid.org/0000-0002-9059-2171)
- Mengxin Lü (ORCID: https://orcid.org/0000-0002-9879-6996)
Institutions
- Shanghai Public Health Clinical Center (CN)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1016/j.aohep.2024.101744
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Shanghai Association for Science and Technology
- Shanghai Municipal Health Commission
- Shanghai Hospital Development Center
- Shanghai Shenkang Hospital Development Center